У нас вы можете посмотреть бесплатно Juvederm Volift Retouch 2 x 0.55ml | Unboxing and Viscosity Test | Medica Depot или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Juvéderm® VOLIFT® Retouch is a hyaluronic acid-based injectable dermal filler designed to address deep skin depressions caused by aging or structural defects. The product's composition includes 17.5 mg of cross-linked hyaluronic acid and a phosphate buffer at a pH of 7.2. Each box contains two syringes with a volume of 0.55 mL, and it is sterilized by moist heat. Juvéderm® VOLIFT® Retouch is intended for use by medical professionals only and is specifically designed for facial contouring and volume restoration. It is particularly effective for areas where facial asymmetry or volume loss in the cheeks, chin, and lips is evident. The filler is injected into the deep dermis or mucosa of the lips, allowing for precise contouring and long-lasting volume correction. The product’s design allows it to integrate smoothly into the skin, providing natural-looking results. The injection process is crucial and requires a deep dermal injection technique by trained professionals. It is important not to inject the product into the periorbital area (eyelids, under-eye area, crow’s feet) or the glabellar region due to potential risks of complications. Intravascular injection must be avoided as it could lead to severe complications such as embolization, ischemia, or infarction. Juvéderm® VOLIFT® Retouch should not be used in patients with untreated epilepsy, a tendency to develop hypertrophic scarring, or hypersensitivity to hyaluronic acid. Patients undergoing treatment must be carefully evaluated, especially those with a history of autoimmune diseases or severe allergies. Medical practitioners should be particularly cautious when treating patients with a history of streptococcal infections or those on anticoagulation therapy, as there is an increased risk of bleeding and hematomas during the procedure. The product is not intended for breast augmentation or reconstruction. Following injection, inflammatory reactions such as redness, swelling, or itching may occur and last for up to a week. At the injection site, there may also be hematomas, induration, nodules, or discoloration. Serious but rare complications include vision impairment, blindness, or tissue